[ad_1]
Washington:
After the US, which has carried out a report 42 million COVID-19 assessments, India has performed the second largest variety of 12 million coronavirus assessments, the White House has stated.
More than 3.5 million folks have examined constructive with the coronavirus and 138,000 died within the US. Globally, greater than 13.6 million have examined constructive and over 586,000 have died.
“With regard to (the coronavirus) testing, we’ve done more than 42 million tests. The second-highest number is 12 million from India. We’re leading the world in testing,” White House Press Secretary Kayleigh McEnany informed reporters at a information convention right here on Thursday.
The White House was responding to questions associated to the coronavirus pandemic within the US.
“We have done more than any country in the world on testing; there’s no doubt about that — 42 million tests. The country with the next highest number is India at 12 million,” McEnany stated.
This report testing, she stated, is in a really stark distinction than the earlier administration.
CBS is reporting that in 2009 underneath Obama-Biden, the Centers for Disease Control and Prevention abruptly suggested states to cease testing for the H1N1 flu and stopped counting particular person circumstances, she stated.
“Ron Klain, Vice President Biden’s former Chief of Staff said this: It is “purely a fortuity that (H1N1) is not one of many nice mass casualty occasions in American historical past. It had nothing to do with us doing something proper.” This is former VP Biden’s Chief of Staff. It just had to do with luck,” she stated.
“Contrary to that, this President led the world in testing; led the world in ventilators — redistributing ventilators for therapeutics; 13 vaccine candidates — one going into phase three clinical trial. This response has been extraordinary and historic. We didn’t pause testing; the Obama-Biden administration did, and that was a shameful decision,” McEnany stated.
There has been encouraging information on vaccines, the press secretary stated.
“Moderna’s vaccine candidate is showing promising signs. They produced a positive, neutral immune response among the 45 participants in the study. This is comparable to what we see in recovered patients. The bottom line is that, so far, we are seeing exactly what you would hope to see in a vaccine. The Moderna vaccine in particular is expected to reach phase three by late July, with 30,000 participants.
“On the therapeutics entrance, I simply need to notice: A really encouraging Regeneron contract. A USD 450 million contract for a monoclonal antibody cocktail. This is a bioengineered model of convalescent plasma, one of many a number of therapeutics obtainable to deal with COVID-19. It can be utilized for prophylaxis and remedy. They say they may have as much as 70 to 300 thousand doses — by the top of the summer season or early fall,” she stated.
As such there may be encouraging information on the therapeutics entrance, McEnany added.
[ad_2]
Source link